Management

This page includes content on healthcare management, including health system, hospital, department and clinic business management and administration. Areas of focus are on cardiology and radiology department business administration. Subcategories covered in this section include healthcare economics, reimbursement, leadership, mergers and acquisitions, policy and regulations, practice management, quality, staffing, and supply chain.

RSS icon
Thumbnail

Nonin Medical appoints new senior leadership

Nonin Medical, based in Minneapolis, made several changes to its senior leadership team as it makes plans to grow and expand.

Largest generic drug company may join PhRMA

The trade association for brand-name drug manufacturers could soon count the largest generic drug maker among its members—and the brand-name companies aren’t entirely comfortable with the idea.

Medical device company Sequana names new chairman

Switzerland-based Sequana Medical has appointed a new chairman to their board of directors as the company expands its international commercialization of its fluid pump. 

ACA co-ops face big risk-adjustment charges

Some of the smallest insurance companies will be the biggest payers into the risk adjustment program established under the Affordable Care Act for this year.

Nearly 600 U.S. clinics could be selling unregulated stem cell treatments

The risks of “stem cell tourism” might be overplayed, according to a new paper published June 30 in the journal Cell Stem Cell. But only because the real risks of unregulated stem cells might actually be within the U.S. 

1.6 million ACA exchange customers dropped out by March

Nearly 13 percent of the 12.7 million people who bought coverage on the Affordable Care Act’s health insurance marketplaces for 2016 had dropped out by the end of March.

athenahealth wants to be the Amazon of healthcare

We live in the age of technology where even babies use tablets. But it seems odd that, while anyone can use technology, doctors can be confounded by the internet. athenahealth hopes to change that by modeling its own “information problem” solution after top technology companies like Amazon.

AstraZeneca takes on FDA over Crestor patent

AstraZeneca’s cholesterol medicine Crestor’s patent protection is set to expire July 8, according to FDA standards, but the company has other plans for the drug. 

Displaying 5729 - 5736 of 6641

Around the web

Cardiovascular Business
Cardiologist compensation still rising, especially in invasive and interventional cardiology

Updated compensation data includes good news for multiple subspecialties. The new report also examines private equity's impact on employment models and how much male cardiologists earn compared to females.

Cardiovascular Business
FDA’s tirzepatide decision creates uncertainty for patients—and leads to a lawsuit

When drugs are on the FDA’s shortage list, outsourcing facilities can produce their own compounded versions. When the FDA removed tirzepatide from that list with no warning, it created a considerable amount of chaos both behind the scenes and in pharmacies all over the country. 

Cardiovascular Business
Cardiology groups cheer new bill that would improve access to Medicare claims data

If passed, this bill would help clinician-led clinical registries explore Medicare data for research purposes. The Society of Thoracic Surgeons and American College of Cardiology both shared public support for the bipartisan legislation. 

Design by Adaptive Theme
Trimed Popup
Trimed Popup